RxDoctor Payments Data

Todd Vogel, MD

Neurological Surgery · Grand Rapids, MINPI 1275791774

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,449 of the $15,076 with a category attached, or 75.9%. 22 manufacturers reported payments, led by Johnson & Johnson at 25.5% of the total. 2025 is the largest year on record at $4,946, 4.1 times the $1,219 reported in 2019.

$15,076in general payments, 2019–2025

Across 481 payments — averaging $31.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$4K
  • Medtronic$4K
  • Icotec Medical Inc.$3K
  • Medical Device Business Services, Inc.$2K
  • Globus Medical$815
  • Depuy Synthes Products, Inc.$432
  • plus $2K from 16 others

What the payments were for

  • Travel & lodging$3,62724%
  • Food & beverage$11,44976%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,076 in reported general payments places this provider in the 75th percentile of 256 neurological surgery providers in Michigan.

See all neurological surgery providers in Michigan →

Medicare billing

Part B allowed, 2024
$147,318
Medicare patients
117
Services billed
417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl20$152
Methylprednisolone23$136
Gabapentin16$127
Mupirocin14$94

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Grand Rapids

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →